Immuno-metabolic crosstalk in osteoarthritis: from mechanisms to therapies
- 1School of Basic Medical Sciences Health Science Center Hunan Normal University , ,
Abstract
Background: Osteoarthritis (OA) is a heterogeneous whole-joint disorder influenced by mechanical stress, aging, previous trauma, genetic susceptibility, subchonrral bone alterations, and localized inflamation.Emerging evidence suggests that immune and metabolic processes alterations may be involved in OA pathogenesis particularly in inflammatory and metabolically dysregulated subtypes.
Content: This narrative review summarizes the bidirectional crosstalk between immune and metabolic processes during OA progression. Human observational studies and experimental models suggest that immune-cell activation and metabolic dysfunction may interact to influence synovial inflammation and cartilage homeostasis although their causal relevance and relative contributions vary across OA phenotypes. We further discuss emerging immunometabolic strategies targeting glycolytic and lipid-metabolic pathways as well as predominantly experimental approaches involving gene editing synthetic biology and stem cell-based therapies.
Conclusion: Integrating multi-omics technologies with personalized medicine may improve patient stratification and dynamic monitoring and could facilitate the future development of more personalized and potentially disease-modifying strategies for OA.Future research should focus on clarifying the dynamic immunometabolic network underlying OA and promoting the clinical translation of innovative strategies through artificial intelligence and interdisciplinary collaboration.
Related
- Metabolic-extracellular matrix crosstalk in hepatocellular carcinoma: mechanisms and targeted intervention
- Metabolic stress and macrophage efferocytosis in osteoarthritis: mechanisms and therapeutic implications
- Discovery of a Small-Molecule mTORC1 Pathway Activator that Enhances Adoptive T-Cell Therapy via Immuno-metabolic Reprogramming of CD8+ T Cells
- Immunosenescence remodels the osteoimmune microenvironment in osteoarthritis: from cellular crosstalk to regenerative therapeutics
- Synovial inflammation and immune-stromal crosstalk in osteoarthritis-related synovial fibroblast research, 2006–2025: a bibliometric analysis
BibTeX
@article{yi2026immunometabolic,
title = {{Immuno-metabolic crosstalk in osteoarthritis: from mechanisms to therapies}},
author = {Yangfei Yi and Ke Ning and Yitong Ding and Fen Yang and Yufei Li and Yi Zhuo},
journal = {Frontiers in immunology},
year = {2026},
month = oct,
doi = {10.3389/fimmu.2026.1946261},
url = {https://europepmc.org/article/PMC/PMC13670026},
note = {CC BY},
}
RIS
TY - JOUR
TI - Immuno-metabolic crosstalk in osteoarthritis: from mechanisms to therapies
AU - Yangfei Yi
AU - Ke Ning
AU - Yitong Ding
AU - Fen Yang
AU - Yufei Li
AU - Yi Zhuo
PY - 2026
DA - 2026/10/01
JO - Frontiers in immunology
DO - 10.3389/fimmu.2026.1946261
UR - https://europepmc.org/article/PMC/PMC13670026
AB - Background: Osteoarthritis (OA) is a heterogeneous whole-joint disorder influenced by mechanical stress, aging, previous trauma, genetic susceptibility, subchonrral bone alterations, and localized inflamation.Emerging evidence suggests that immune and metabolic processes alterations may be involved in OA pathogenesis particularly in inflammatory and metabolically dysregulated subtypes. Content: This narrative review summarizes the bidirectional crosstalk between immune and metabolic processes during OA progression. Human observational studies and experimental models suggest that immune-cell activation and metabolic dysfunction may interact to influence synovial inflammation and cartilage homeostasis although their causal relevance and relative contributions vary across OA phenotypes. We further discuss emerging immunometabolic strategies targeting glycolytic and lipid-metabolic pathways as well as predominantly experimental approaches involving gene editing synthetic biology and stem cell-based therapies. Conclusion: Integrating multi-omics technologies with personalized medicine may improve patient stratification and dynamic monitoring and could facilitate the future development of more personalized and potentially disease-modifying strategies for OA.Future research should focus on clarifying the dynamic immunometabolic network underlying OA and promoting the clinical translation of innovative strategies through artificial intelligence and interdisciplinary collaboration.
SN - 1664-3224
ER -